NattoPharma organizational changes for growth
Announcing permanent CEOs; addition of SVP Global Sales & MarketingOslo, Norway and Edison, NJ (June 5, 2018) — Thanks to positive performance and strong growth with both NattoPharma and Kaydence Pharma, the pharmaceutical business spin-off, each company’s respective Boards are excited to announce executive roles, as well as the addition of a new team member to lead NattoPharma’s Sales & Marketing teams. • Daniel Rosenbaum, former NattoPharma CEO, has served as the interim CEO of Kaydence Pharma since the spin-off in December 2017. The Kaydence Pharma Board of Directors is extremely